| Uday Reddy, MD | |
|
71 Haynes St, Suite 1221, Manchester, CT 06040-4131 | |
| (860) 533-6595 | |
| Not Available |
| Full Name | Uday Reddy |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 28 Years |
| Location | 71 Haynes St, Manchester, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245203462 | NPI | - | NPPES |
| P00057742 | Other | CT | RAILROAD MEDICARE |
| 001396151 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 039615 (Connecticut) | Secondary |
| 208M00000X | Hospitalist | 039615 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - South Bay | Harbor city, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Southern California Permanente Medical Group | 6002729175 | 7951 |
News Archive
HRH Princess Haya Al Hussein of Jordan yesterday called for more investment in medical research in a keynote speech at a medical conference hosted by the Aswan Heart Centre.
BioCurex Inc. today announced its first set of results supporting the use of the BioCurex RECAF blood test to monitor cancer therapy. The test included samples from 27 human patients with early stages of breast cancer that were tested before and after surgery. As a control, 15 samples from healthy individuals were also tested.
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
Emerging Healthcare Solutions, Inc. enthusiastically welcomed a highly anticipated report that Apple has unveiled the new iPhone 4.0 Operating System, which the Company believes will greatly benefit the MedAnywhere medical app currently in development. Specifically, new multitasking ability can be applied so that a physician can initiate patient monitoring subroutines without having to exit the MedAnywhere live communications portal.
› Verified 9 days ago
| Entity Name | Southern California Permanente Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770515280 PECOS PAC ID: 6002729175 Enrollment ID: O20031110000678 |
News Archive
HRH Princess Haya Al Hussein of Jordan yesterday called for more investment in medical research in a keynote speech at a medical conference hosted by the Aswan Heart Centre.
BioCurex Inc. today announced its first set of results supporting the use of the BioCurex RECAF blood test to monitor cancer therapy. The test included samples from 27 human patients with early stages of breast cancer that were tested before and after surgery. As a control, 15 samples from healthy individuals were also tested.
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
Emerging Healthcare Solutions, Inc. enthusiastically welcomed a highly anticipated report that Apple has unveiled the new iPhone 4.0 Operating System, which the Company believes will greatly benefit the MedAnywhere medical app currently in development. Specifically, new multitasking ability can be applied so that a physician can initiate patient monitoring subroutines without having to exit the MedAnywhere live communications portal.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Uday Reddy, MD 71 Haynes St, Suite 1221, Manchester, CT 06040-4131 Ph: (860) 533-6595 | Uday Reddy, MD 71 Haynes St, Suite 1221, Manchester, CT 06040-4131 Ph: (860) 533-6595 |
News Archive
HRH Princess Haya Al Hussein of Jordan yesterday called for more investment in medical research in a keynote speech at a medical conference hosted by the Aswan Heart Centre.
BioCurex Inc. today announced its first set of results supporting the use of the BioCurex RECAF blood test to monitor cancer therapy. The test included samples from 27 human patients with early stages of breast cancer that were tested before and after surgery. As a control, 15 samples from healthy individuals were also tested.
Questcor Pharmaceuticals, Inc. today announced the U.S. Food and Drug Administration (FDA) has approved Questcor's supplemental new drug application (sNDA) for H.P. Acthar® Gel (repository corticotropin injection) in the treatment of infantile spasms (IS), an ultra-rare orphan disorder affecting approximately 2,000 American children annually. IS is a devastating and potentially life-threatening form of epilepsy seen in infancy and early childhood.
Emerging Healthcare Solutions, Inc. enthusiastically welcomed a highly anticipated report that Apple has unveiled the new iPhone 4.0 Operating System, which the Company believes will greatly benefit the MedAnywhere medical app currently in development. Specifically, new multitasking ability can be applied so that a physician can initiate patient monitoring subroutines without having to exit the MedAnywhere live communications portal.
› Verified 9 days ago
Robert C Morgan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 71 Haynes St, Suite 1221, Manchester, CT 06040 Phone: 860-533-6595 | |
Salah Alsalahi, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 71 Haynes St, Manchester, CT 06040 Phone: 860-646-1222 | |
Syera Mathews, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 71 Haynes St, Manchester Memorial Hospital, Manchester, CT 06040 Phone: 860-646-1222 Fax: 860-533-2975 | |
Edward Sampt, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 71 Haynes St, Suite 1221, Manchester, CT 06040 Phone: 860-533-6595 | |
Faria Mahmood, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 71 Haynes St, Suite 1221, Manchester, CT 06040 Phone: 860-533-6595 | |
Uma Rani Madhusudana, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 71 Haynes St, Manchester, CT 06040 Phone: 860-646-1222 | |
Nermina Bukalo, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 71 Haynes St, Manchester, CT 06040 Phone: 860-540-6595 |